(Bloomberg Opinion) -- As panic-ridden consumers stock up on essentials, kitchen pantries are looking like a blast from the processed-food past: boxes of Kraft macaroni and cheese, cans of Bumble Bee tuna, Kellogg’s Frosted Flakes, Shake ‘N Bake, etc. Brands of yesteryear that had been struggling to find their place in a new health-conscious society are suddenly having a moment once again. But a moment is probably all it will be, not a new normal, which is why packaged-food companies shouldn’t get too comfortable about their comfort food.The Covid-19 pandemic and shelter-in-place orders have led consumers to revert to old ways of shopping in search of ready-made meals and foods with long shelf lives. Parents who are working from home during this time are multitasking like never before, taking on the role of cook, housekeeper, teacher, disciplinary and full-time employee all at once in a Groundhog Day-like loop. As such, traditional meal times have blurred, and in some cases snacks are...
Powell said in prepared remarks Wednesday that the depth and length of a recession can “leave behind lasting damage," suggesting that those inside the Fed see slim chances of a V-shaped recovery. ...
Six months ago, disturbing liver biopsies suggesting some patients in an FDA Phase 2b study of CymaBay Therapeutics (CBAY) suffered inflamed and destroyed liver cells forced the company to suspend nonalcoholic steatohepatitis (NASH) treatment trials of its seladelpar liver treatment drug -- and cost CymaBay stock 75% of its market cap. Six months later, a new study just showed no evidence that seladelpar causes liver damage, giving CymaBay the all-clear to proceed with its trials, and more than doubling the stock's share price on Tuesday.Analysts rushed to hail the results, and as of today, every one of the six analysts tracked by TipRanks, who have voiced an opinion on CymaBay stock in the last two months, rate the stock a "buy" -- with an average target price of $5.15 on the shares (23% upside from Tuesday's closing price).Some analysts think it could be worth even more than that -- Oppenheimer's Jay...
